Visiongain Launches Global Translational Regenerative Medicine Market Prospects 2017-2027: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies
14 nov. 2017 08h04 HE
|
Visiongain Ltd
LONDON, Nov. 14, 2017 (GLOBE NEWSWIRE) -- The translational regenerative medicine market has been undergoing considerable changes over the last few years. There are a number of therapies that have...